Respiratory Syncytial Virus (RSV) — Brookshire's

Fact checked by Robert Carlson, MD

Jan 10

3 min read

RSV Vaccine Candidate Granted FDA Fast Track Status

Meissa Vaccines MV-012-968 is an investigational, live attenuated vaccine for protection against respiratory syncytial virus infection

sleeping toddler boy

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Oct 8

3 min read

RSV Vaccine Candidate Produced 10-20 Fold Increase in Virus-Killing Antibodies

RSVpreF vaccine candidate has the potential to prevent Respiratory Syncytial Virus disease in infants by immunizing pregnant women

pregnant woman protecting her baby

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Oct 3

4 min read

$51 Million Dollars Raised For RSV Vaccine Development

Icosavax IVX-121 RSV vaccine candidate incorporates a stabilized prefusion F antigen

older woman healthy

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Sep 5

3 min read

FDA Breakthrough Therapy Designation Granted for Respiratory Syncytial Virus Vaccine

Janssen Ad26.preF based RSV vaccine candidate launched a phase 2b clinical study

older man contemplating

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Aug 15

3 min read

ResVax Demonstrated Significant Vaccine Efficacy Against Infant Pneumonia Early in Life

Novavax ResVax is an aluminum adjuvanted respiratory syncytial virus fusion protein recombinant nanoparticle vaccine

happy little girl with dad

Respiratory Syncytial Virus (RSV)

Sponsored Links:

Discounts Appointments Clinical Trials Lab Tests